Engineering metabolic pathways in plants by multigene transformation by Zorrilla López, Uxue et al.
 Engineering metabolic pathways in plants
by multigene transformation
UXUE ZORRILLA-LÓPEZ#,1, GEMMA MASIP#,1, GEMMA ARJÓ2, CHAO BAI1, RAVIRAJ BANAKAR1, 
LUDOVIC BASSIE1, JUDIT BERMAN1, GEMMA FARRÉ1, BRUNA MIRALPEIX1, EDUARD PÉREZ-MASSOT1, 
MAITE SABALZA1, GEORGINA SANAHUJA1, EVANGELIA VAMVAKA1, RICHARD M. TWYMAN3, 
PAUL CHRISTOU1,4, CHANGFU ZHU1 and TERESA CAPELL*,1
1Department of Plant Production and Forestry Science, School of Agrifood and Forestry Science and Engineering 
(ETSEA), University of Lleida-Agrotecnio Center, Lleida, Spain, 2Department of Medicine, Institute of Biomedical 
Research (IRB), University of Lleida, Lleida, Spain, 3School of Life Sciences, University of Warwick, Coventry, UK 
and 4Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
ABSTRACT  Metabolic engineering in plants can be used to increase the abundance of specific 
valuable metabolites, but single-point interventions generally do not improve the yields of target 
metabolites unless that product is immediately downstream of the intervention point and there is 
a plentiful supply of precursors. In many cases, an intervention is necessary at an early bottleneck, 
sometimes the first committed step in the pathway, but is often only successful in shifting the 
bottleneck downstream, sometimes also causing the accumulation of an undesirable metabolic 
intermediate. Occasionally it has been possible to induce multiple genes in a pathway by controlling 
the expression of a key regulator, such as a transcription factor, but this strategy is only possible 
if such master regulators exist and can be identified. A more robust approach is the simultane-
ous expression of multiple genes in the pathway, preferably representing every critical enzymatic 
step, therefore removing all bottlenecks and ensuring completely unrestricted metabolic flux. This 
approach requires the transfer of multiple enzyme-encoding genes to the recipient plant, which 
is achieved most efficiently if all genes are transferred at the same time. Here we review the state 
of the art in multigene transformation as applied to metabolic engineering in plants, highlighting 
some of the most significant recent advances in the field. 
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Introduction
Most agronomic traits in plants are controlled by multiple genes, 
as is also the case for the synthesis of complex organic compounds 
from primary and secondary metabolisms, which often represent 
the outputs of long and convoluted metabolic pathways. Therefore, 
genetic engineering has seen a progressive change from single-
gene intervention to multigene transformation to tackle increasingly 
ambitious objectives (Halpin, 2005).
In the early years of plant biotechnology, gene transfer experi-
ments typically involved two transgenes: one selectable marker 
under the control of a constitutive promoter to facilitate the selec-
tive propagation of transformed cells, and a ‘primary transgene’ or 
‘gene of interest’ which could be under the control of any promoter 
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and was intended to alter the phenotype of the plant in a specific 
manner (Peremarti et al., 2010). This principle was adopted in 
the first examples of metabolic engineering, which involves the 
modulation of endogenous metabolic pathways to increase flux 
towards particular desirable molecules or even new molecules 
(Capell and Christou, 2004). Multigene transformation (MGT) is 
being gradually accepted as an approach to generate plants with 
more ambitious phenotypes, including more complex examples of 
metabolic engineering (Naqvi et al., 2009). To this end, methods 
had to be developed for the coordinated expression of larger groups 
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of genes (Capell and Christou, 2004) to attain objectives, such 
as: (a) enhance the activity of enzymes at multiple rate-limiting 
steps in target pathways, e.g. by expression of enzymes that are 
released from feedback inhibition; (b) increase the availability of 
upstream precursors to increase flux through the target pathway; 
(c) modulate pathway branch points to prevent the loss of flux; and 
(d) promote the development of sink compartments to store target 
compounds (Fig. 1) (Zhu et al., 2013).
Examples of metabolic engineering in plants include primary 
metabolic pathways (carbohydrates, amino acids, and lipids) and 
secondary metabolic pathways (e.g. alkaloids, terpenoids, flavo-
noids, lignins, quinones, and other benzoic acid derivatives; Gomez 
Galera et al., 2007). These pathways generate a large number of 
compounds that are useful to humans, including energy-rich foods, 
vitamins and many different pharmaceuticals. In this review, we 
focus on the metabolic engineering of vitamins, polyunsaturated 
fatty acids, and secondary metabolites, because they provide il-
lustrative examples of applied MGT.
The scope of the challenge
The simultaneous transfer of multiple genes into plants (co-
transformation) can be achieved using two main approaches, one 
involving linked genes (multiple genes on the same plasmid) and 
the other involving unlinked genes (different genes on different 
plasmids). The two methods can be used with both major strategies 
for gene transfer to plants, i.e. transformation with Agrobacterium 
tumefaciens and direct DNA transfer (Naqvi et al., 2009).
Multiple linked genes can be transferred by Agrobacterium-
mediated transformation using standard binary vectors contain-
ing multiple genes within a single T-DNA or multiple T-DNAs 
each containing a single gene, whereas for direct DNA transfer 
methods the genes can be linked on conventional vectors (Naqvi 
et al., 2009). The transgenes tend to integrate at a single locus, 
although the precise arrangement of multiple T-DNAs depends on 
the bacterial strain (Twyman et al., 2002). This strategy is robust 
for a small number of input genes, but as the number increases, 
the vectors become increasingly cumbersome and unstable; the 
effective upper capacity using standard vectors is approximately 
50 kb due to dwindling efficiency (Naqvi et al., 2009). High-capacity 
binary vectors (BIBAC, BIBAC2, and TAC) that allow the transfer 
of up to 200 kb of insert DNA are discussed below.
Multiple unlinked genes can be introduced by Agrobacterium-
mediated transformation if the bacteria contain multiple compatible 
plasmids carrying separate T-DNAs or if the inoculum comprises 
a mixture of bacterial strains carrying different vectors; however, 
the ratio of different input genes is difficult to control and multiple 
T-DNAs tend to integrate inefficiently (Naqvi et al., 2009). Cur-
rently, only direct DNA transfer can introduce routinely and reliably 
multiple unlinked genes into plants, allowing plants carrying up to 
15 different transgenes to be produced in one generation (Naqvi 
et al., 2009).
Direct DNA transfer with separate vectors usually results in 
transgene integration at a single random locus in the form of a 
multigene array, regardless of how many different transformation 
cassettes have been used (Altpeter et al., 2005; Kohli et al., 2006). 
The integrated array may contain any number of transgenes from 1 
to n (where n is the maximum input gene number) with the distribu-
tion within the transgenic population tending to describe a skewed 
normal curve as would be expected from random sampling with 
selection against zero integration events and for larger numbers 
of integrated transgenes (Kohli et al., 2003). Input transgenes 
once integrated remain linked and do not segregate in subsequent 
generations (Wu et al., 2002; Altpeter et al., 2005). This feature is 
important when large numbers of genes are considered, because 
a much larger transgenic population would be required if each 
integration event were independent (Altpeter et al., 2005).
Chen et al., (1998) successfully transformed rice (Oryza sativa) 
plants by particle bombardment with 13 separate plasmids con-
taining different marker genes, and regenerated plants carrying 
and expressing all the input genes at one locus. Subsequently, 
Wu et al., (2002) transformed rice with nine transgenes also by 
particle bombardment and found that nonselected transgenes 
were present along with the selectable marker in approximately 
70% of the plants and that 56% carried seven or more genes. This 
percentage was much higher than expected given the independent 
integration frequencies, in accordance with a model suggesting 
that the integration of one transgene promotes the cointegration 
of more input DNA at the same locus (Kohli et al., 1998). All nine 
transgenes were expressed, and the expression of each gene was 
independent of the others (Wu et al., 2002) (Table 1).
The position of transgene integration also influences the level 
and stability of expression in both transformation methods. For 
example, the transgenes can be integrated at a silencing locus 
(position-dependent silencing) or influenced by nearby regulatory 
sequences, such as enhancers (Topping et al., 1991). The inte-
gration mechanism does not appear to be sequence dependent. 
Contrary to the prevailing view that the repetitious use of the same 
promoter may lead to the likelihood of transcriptional silencing, 
Fig. 1. Strategies to modulate organic compound levels in plants. A 
and B are the precursors of C; C is the target product; D is the result of 
the target product conversion. (1) Modification of the activity of enzymes 
implicated in rate-limiting steps in the target pathway by modulation of 
one or two key enzymes, or multiple enzymes. (2) Upstream precursors 
enhancement by increasing flux through the pathway by overexpressing 
the enzyme(s) that catalyze(s) the first committed step of the pathway. 
(3) Blocked pathway branch points by RNA interference or antisense. (4) 
Enhanced accumulation of target metabolite by increasing sink compart-
ments. (Zhu et al., 2013).
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a number of transgenic plants have been generated containing 
five or more transgenes controlled by the same promoter with 
no untoward effects (Naqvi et al., 2009). Particle bombardment 
often generates large, high-copy-number transgenic loci, which 
are believed to be prone to instability and silencing, but there are 
many instances where this is not the case. For example, Golden 
Rice provides a clear example in which higher transgene copy 
numbers correspond to higher expression levels, ultimately lead-
ing to more b-carotene production in the endosperm (Datta et al., 
2003). Bacillus thuringiensis (Bt)-resistant rice containing multiple 
transgene copies also performed well against a number of insect 
pests in the greenhouse (Maqbool and Christou, 1999; Maqbool 
et al., 2001) and under field conditions (Tu et al., 2000; Ye et al., 
2001), indicating that the transgenes were expressed efficiently.
Development of multigene transformation methods
Stacking and retransformation
Prior to the development of simultaneous transfer methods 
suitable for many genes, multiple transgenes could be stacked 
in plants through successive rounds of crosses between differ-
ent transgenic lines (Ma et al., 1995; Datta et al., 2002) or by the 
retransformation of transformed plants with additional transgenes 
(Jobling et al., 2002). However, both methods are time-consuming 
and labor-intensive because of the need of multiple breeding 
generations to complete the stacking process and the important 
segregation risk, unless all the genes can be stacked together in 
a homozygous plant. Both the time necessary for stacking and the 
segregation risk increase with the number of transgenes. In the 
case of sequential transformation, multiple selectable markers (or 
marker excision and reuse) are also required.
Standard T-DNA and bombardment vectors
Both Agrobacterium-mediated transformation and direct DNA 
transfer involve the use of vectors that are optimized to replicate 
efficiently in Escherichia coli and to facilitate subcloning, which 
benefit from the vector remaining small. Vectors become increas-
ingly unstable and prone to eject DNA when too much is inserted. 
The shear forces during particle bombardment can lead to frag-
mentation as well. It also becomes increasingly difficult to find 
restriction enzymes that cut at a unique site as more transgenes 
are introduced into the vector. Therefore, as the number of input 
genes increases, standard vectors are largely restricted to use with 
unlinked transgenes. As discussed above, Agrobacterium-mediated 
transformation turns out to be progressively less efficient as the 
number of separate T-DNAs increases, so for the highest numbers 
of transgenes only direct DNA transfer can be carried out with 
standard vectors. This problem has been solved to a certain extent 
by transforming plants with two bacterial strains, each carrying 
T-DNAs containing two or more transgenes; however, direct DNA 
transfer remains efficient with up to 15 unlinked transgenes and 
no upper limit has yet been determined. In the context of metabolic 
engineering, standard expression vectors have allowed the stable 
expression of several transgenes in maize (Zea mays) to recreate 
partial metabolic pathways (Zhu et al., 2008; Naqvi et al., 2010).
High-capacity T-DNA vectors
The limitations of MGT using A. tumefaciens have been ad-
dressed in part by the development of systems based on high-
capacity artificial chromosome vectors with the ability to integrate 
large DNA fragments. These systems use the capacity of bacterial 
artificial chromosome (BAC) vectors and combine them with the 
components of standard binary vectors, resulting in chimeric binary 
vectors, such as BIBAC and TAC. Initially, these vectors still suf-
fered from the cumbersome cloning procedure due to the lack of 
unique restriction sites, but this issue has been taken care of by 
combining the vectors with Gateway site-specific recombination 
technology (Vega et al., 2008). Multisite and MultiRound Gateway 
systems have been used to integrate up to seven genes into the 
plant genome (Buntru et al., 2013).
Split reading frames
The use of linker peptides can also facilitate MGT by letting 
several polypeptides to be encoded in a single open reading 
frame (ORF) controlled by a single promoter. For example, the 
Foot-and-mouth disease virus 2A polyprotein system allows the 
coexpression of up to four polypeptides in tobacco (Nicotiana 
tabacum) plants (Møldrup et al., 2011; Lee et al., 2012; Sun et 
Number of input 
transgenes Plant Results References 
Three Potato 17% of plants contained all input transgenes. Romano et al. (2003) 
Three Rice 60% of all transgenic lines carried all three transgenes. Sivamani et al. (1999); Maqbool et al. (2001) 
Four Maize Introduced psy1 and crtI (carotenoid pathway), Dhar (ascorbate pathway) and folE (folate pathway) using an 
unlinked direct DNA transfer co-transformation strategy to increase levels of β-carotene, folate and ascorbate 
in the endosperm. Achieved significant increases in all three nutrients providing the first example towards 
‘super-nutritious’ cereals. 
Naqvi et al. (2009) 
Four Rice 50% of transgenic plants contained all four input transgenes. Wu et al. (2002); Altpeter et al. (2005) 
Four Rice More than 20% of the plants contained and expressed all four input transgenes (fully assembled secretory 
antibody). 
Nicholson et al. (2005) 
Five Rice All transgenic plants contained at least two transgenes (mostly marker genes) and 16% contained all input 
transgenes (five). 
Agrawal et al. (2005) 
Up to five Maize Introduced psy1, crtI, lycb, bch and crtW genes using an unlinked direct DNA transfer co-transformation 
strategy aiming to generate a range of genotypes and phenotypes to dissect the carotenoid pathway. 
Recovered maize plants with a range of phenotypes reflecting different carotenoid profiles. 
Zhu et al. (2008) 
Nine Rice Non-selected transgenes were present along with the selectable marker: 70% of the plants; 56% carried 
seven or more transgenes. 
Wu et al. (2002) 
Thirteen Rice 85% of the plants contained more than two, and 17% more than nine of the introduced transgenes. Chen et al. (1998) 
TABLE 1
EXAMPLES OF UNLINKED GENES FOR CO-TRANSFORMATION USING MULTIGENE TRANSFORMATION IN PLANTS
Adapted from (Naqvi et al., 2010).
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al., 2012). The 2A linker is less than 20 amino acids in length 
and has the ability to cleave its own C-terminus, thus releasing 
downstream polypeptides after synthesis (Halpin, 2005). In the 
context of metabolic engineering, the Paracoccus crtW and crtZ 
genes were simultaneously expressed as a polyprotein with an 
intervening 2A linker in transgenic tobacco and tomato (Solanum 
lycopersicum) plants to generate novel ketocarotenoids (Ralley et 
al., 2004). More recently, the genes for phytoene synthase and caro-
tene desaturase have been expressed in soybean (Glycine max) 
seeds with an intervening 2A linker, using either the b-conglycinin 
or the cauliflower mosaic virus 35S (CaMV35S) promoter (Kim et 
al., 2012). Only the b-conglycinin promoter produced seeds with 
orange endosperm, indicating the accumulation of b-carotene, and 
this corresponded to high mRNA levels in the transgenic seeds. In 
contrast, the CaMV35S construct generated high mRNA levels in 
the leaves of transgenic plants (Kim et al., 2012). Attributes and 
limitations of the key MGT methods are illustrated in Fig. 2.
Controlling the expression of multiple transgenes
As discussed above, a number of studies have shown that the 
same promoter can be used to drive multiple transgenes without 
negative effects, such as the strong endosperm-specific expression 
of three transgenes in maize achieved using the barley (Hordeum 
vulgare) D-hordein promoter (Naqvi et al., 2009). Other studies have 
indicated that repetitive use of the same promoter can encourage 
(although probably not directly trigger) transgene silencing (Mourrain 
et al., 2007). This observation may reflect several underlying factors, 
such as the presence of potential secondary structures that could 
interact in trans to promote de novo methylation, or the intrinsic 
activity of the promoters generating enough mRNA to saturate the 
polyadenylation machinery of the cell, allowing the formation of 
hairpin RNAs. These effects are also context dependent, based 
on the integration site and the juxtaposition of transgene copies, 
some of which may integrate ‘head-to-head’, thus encouraging the 
formation of double-stranded RNA at the junction of two opposing 
promoters (Kohli et al., 2006).
Therefore, although it is by no means certain that using the 
same promoter for different transgenes will have a negative impact 
on transgene expression, various strategies have been devised to 
avoid the possibility. Examples include the use of natural diverse 
promoters with the same or similar activity (for instance, five differ-
ent endosperm-specific promoters were used in maize to achieve 
Gene stacking Re-transformation 
Unlinked 
transgenes 
Linked transgenes 
(BIBAC/TAC) 
Split reading 
frames 
Operons 
x + + + + + 
A B C D E F 
Fig. 2. Multigene transformation (MGT) methods for metabolic engineering. Schematic summary of the principles of different methods for multigene 
transfer. Each panel shows a different method and charts the origin, fate, and activity of two different transgenes (red and blue blocks, with promoters 
shown as sideways arrows). The corresponding products at the level of mRNA (undulating lines) and polypeptides (discs) are shown in matching colors. 
(A) In the gene stacking approach, plants already carrying transgenes 1 and 2 are crossed to bring both genes into the same line. The genes are integrated 
and expressed independently (diagonal slash) and may therefore segregate in later generations. Therefore, a backcross program is needed to bring the 
two transgenes to homozygocity. (B) In the retransformation approach, plants already carrying transgene 1 are transformed with transgene 2, to bring 
both genes into the same line. The genes are integrated and expressed independently (diagonal slash) and may therefore segregate in later generations. 
A backcross program is also needed in this case to bring the two transgenes to homozygocity. (C) In the unlinked transformation approach, transgenes 
1 and 2 are introduced into wild-type plants using separate vectors. All genes tend to integrate at the same locus, which is random, and may integrate 
in tandem (shown here) or in head-to-head or tail-to-tail conformations, occasionally with intervening genomic DNA sequences. Although panels (A-C) 
show individual transgenes as blue and red blocks, the same principles of integration and segregation also apply to groups of linked transgenes. (D) In 
the linked transformation approach, the transgenes are arranged in tandem on a single vector. The entire construct tends to integrate so the integrated 
transgenes are arranged in the same order as on the vector. This approach becomes increasingly difficult with more transgenes, unless high-capacity 
BIBAC/TAC vectors are employed. (E) In the split reading frame approach, two genes are expressed as a fusion protein linked by the 2A peptide from the 
Food-and-mouth disease virus, resulting in the expression of polycistronic mRNA and a polyprotein, which is self-cleaved into proteins 1 and 2, although 
each retains part of the 2A peptide (black circles). (F) In the operon approach, two or more genes are expressed as an operon yielding a polycistronic 
mRNA, but the proteins are translated independently via internal ribosome entry sites. This approach is only feasible for genes expressed in plastids 
and is therefore suitable for plants, such as tobacco and a small number of other species that are amenable to plastid transformation (as shown), but 
not currently for cereal crops, such as maize (shown in the other panels).
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the high-level expression of five carotenogenic genes (Zhu et al., 
2008), and the use of synthetic or modified promoters to reduce 
the amount of sequence identity (Naqvi et al., 2010; Peremarti et 
al., 2010).
Most promoters used in plant biotechnology are unidirectional, 
but bidirectional promoters are becoming increasingly useful for 
MGT because they allow the simultaneous expression of two gene 
products. For example, the human b-casein gene and a bacterial 
marker gene encoding luciferase have been expressed using the 
auxin-inducible, bidirectional mannopine synthase (mas) promoter 
in transgenic potato (Solanum tuberosum cv. Bintje) plants to 
increase their nutritional value (Chong et al., 1997).
Promoter activity depends on the availability and activity of the 
transcription factors, so that the expression of such transcription 
factors can activate several target genes. For example, ectopic 
expression of the maize C1 and R chimeric transcription factors in 
soybean upregulated a suite of endogenous isoflavonoid biosyn-
thetic genes encoding phenylalanine ammonia-lyase, cinnamic acid 
4-hydroxylase, chalcone isomerase, chalcone reductase, flavanone 
3-hydroxylase, dihydroflavonol reductase, and flavonol synthase, 
doubling the isoflavonoid levels in the seeds (Yu et al., 2003).
The number of promoters can also be reduced by using the 
split ORF method based on the 2A linker peptide discussed above, 
or operon-based methods in which the genes are arranged in 
tandem to yield a polycistronic mRNA, of which the ORFs are 
translated independently. The latter method is only suitable for 
plastid transformation, because the plastid genome is arranged 
into operons reflecting its prokaryotic origin. Plastid transformation 
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Antheraxanthin
γ-Carotene
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β-Cryptoxanthin
Zeaxanthin
Pyruvate + GA3P DXP MEP HMBPP
IPP DMAPP
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Fig. 3. Carotenoid biosynthetic pathway in plants and equivalent steps in bacteria. Enzymes in the red ovals are from bacteria. Abbreviations: 
CRTB, bacterial phytoene synthase; CRTI, bacterial phytoene desaturase, which catalyze all desaturation and isomerization reaction from phytoene 
to lycopene; CRTISO, carotenoid isomerase; CRTY, bacterial lycopene b-cyclase; CRTZ, bacterial b-carotene hydroxylase; CYP97C, heme-containing 
cytochrome P450 carotene e-ring hydroxylase; DMAPP, dimethylallyl diphosphate; DXP, 1-deoxy-D-xylulose 5-phosphate; DXR, DXP reductoisomerase; 
DXS, DXP synthase; GA3P, glyceraldehyde 3-phosphate; GGPP, geranylgeranyl diphosphate; GGPPS, GGPP synthase; HDR, HMBPP reductase; HMBPP, 
hydroxymethylbutenyl 4-diphosphate; HYDB, b-carotene hydroxylase [non-heme di-iron b-carotene hydroxylase (BCH) and heme-containing cytochrome 
P450 b-ring hydroxyalses (CYP97A and CYP97B)]; IPP, isopentenyl diphosphate; IPPI, isopentenyl diphosphate isomerase; LYCB, lycopene b-cyclase; 
LYCE, lycopene e-cyclase; MEP, methylerythritol 4-phosphate; PDS, phytoene desaturase; PSY, phytoene synthase; VDE, violaxanthin deepoxidase; 
ZDS, ζ-carotene desaturase; ZEP, zeaxanthin epoxidase; Z-ISO, ζ-carotene isomerase. See Farré et al., 2010, 2011. 
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with operon-like multigene constructs has been used to produce 
astaxanthin in tobacco by expressing b-carotene ketolase and 
b-carotene hydroxylase (Hasunuma et al., 2008). Similarly, the 
production of polyhydroxybutyric acid (PHB) in plastids has been 
achieved by expressing the phbC-phbB-phbA genes of Ralstonia 
eutropha using the T7g10 promoter (Lössl et al., 2005).
Combinatorial transformation
One of the key challenges in metabolic engineering is that any 
targeted pathway must be understood in detail before interventions 
are made, to avoid wasting resources on the development of futile 
transgenic lines. In other words, for the longer and more complex 
pathways, large numbers of transgenic lines must be developed and 
tested independently before the most suitable intervention points are 
identified. Combinatorial transformation, a concept developed by 
Zhu et al., (2008), elegantly solves this challenge and simultaneously 
turns the irritating random nature of transgene integration during 
gene transfer to plants into an advantage. The approach is based 
on the creation of metabolic libraries comprising plants transformed 
with random selections of particular transgenes. For example, the 
targeted analysis of five transgenes would require the generation 
of five transgenic lines carrying individual transgenes, plus other 
lines carrying combinations (perhaps created by stacking), each 
of which would then be subject to metabolic profiling to determine 
the impact on the target pathway. In combinatorial transformation, 
this idea is reversed by taking advantage of the scattergun nature 
of transgene integration: instead of selecting specific transgenic 
lines containing particular combinations of transgenes, the aim is 
to look at all the transgenic lines and with as much diversity as 
possible. Combinatorial transformation with five transgenes would 
therefore generate many different lines, some containing single 
transgenes, others two or three or four, and some with all five. These 
lines constitute a diverse library of metabolic potential, produced 
in a single generation. Hence, subsequent metabolic profiling 
helps to identify bottlenecks in the pathway and the best interven-
tion points, even if effective intervention can only be achieved by 
multiple transgenes. The combinatorial approach is analogous to 
the use of factorial designs to test different parameters rather than 
focusing on the variation of one parameter at a time.
In the context of metabolic engineering, the carotenoid biosyn-
thesis pathway in maize has been investigated by combinatorial 
transformation, allowing the identification and complementation of 
rate-limiting steps that affect the accumulation of b-carotene and 
other nutritionally important carotenoids, such as lutein, zeaxanthin, 
and lycopene. This approach has also allowed the pathway to be 
extended beyond its natural end-point to produce compounds, 
such as astaxanthin, revealing competition between b-carotene 
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Fig. 4. Vitamin E biosynthesis in plants 
(Farré et al., 2012). Tocochromanols are syn-
thesized on the inner chloroplast membrane 
from precursors derived from the shikimate 
and methylerythritol 4-phosphate (MEP) 
pathways. The shikimate pathway contributes 
the head-group precursor homogentisic acid 
(HGA), whereas the MEP pathway gives rise 
to the side-chain precursors phytyldiphosphate 
(PDP) and geranylgeranyldiphosphate (GGDP). 
The first committed step in the reaction is the 
cytosolic conversion of p-hydroxyphenylpyruvic 
acid (HPP) to HGA by p-hydroxyphenylpyruvic 
acid dioxygenase (HPPD). HGA is then prenyl-
ated with either PDP or GGDP to produce the 
intermediates 2-methyl-6-phytyl benzoquinone 
(MPBQ) and 2-methyl-6-geranylgeranylplasto-
quinol (MGGBQ). A second methyl group is 
added by MPBQ methyltransferase (MPBQ-
MT) in the tocopherol branch and MGGBQ 
methyltransferase (MGGBQ-MT) in the tocotri-
enol branch, producing the intermediates 3-di-
methyl-5-phytyl-1,4-benzoquinone (DMPBQ) 
and 2-dimethyl-6-geranylgeranylbenzoquinol 
(DMGGBQ). All four of these intermediates 
are substrates for tocopherol cyclase (TC), 
which produces d and g tocopherols and toco-
trienols. Finally, g-tocopherol methyltransferase 
(g-TMT) catalyses a second ring methylation 
to yield a and b tocopherols and tocotrienols. 
Other abbreviations: GGDR, geranylgeranyl 
diphosphate reductase; HGGT; homogentisate 
geranylgeranyl transferase; HPT, homogentis-
ate phytyltransferase. PDS, VTE1, VTE2, VTE3 
and VTE4 correspond to genes cloned from 
Arabidopsis Thaliana that are homologous to 
HPPD, HPT, MPBQ-MT, TC, and g-TMT genes, 
respectively.
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hydroxylase and bacterial b-carotene ketolase for substrates (Zhu 
et al., 2008).
Combinatorial transformation has also been used to combine 
genes from several different metabolic pathways to identify com-
binations that allow the simultaneous accumulation of different 
compounds. For example, maize plants had been generated that 
coincidently accumulated high levels of vitamins A, C and B9 (folate) 
(Naqvi et al., 2009).
Synthetic biology as the next step for multigene meta-
bolic engineering
Synthetic biology describes the de novo assembly of genetic 
systems using prevalidated components (Haseloff and Ajioka, 
2009). In the context of metabolic engineering in plants, a syn-
thetic biology approach would utilize specific promoters, genes, 
and other regulatory elements to create ideal genetic circuits that 
facilitate the accumulation of particular metabolites. The concept of 
synthetic biology creates engineering and mathematical modeling 
to predict and test the behavior of the resulting system, which can 
be considered as the next step in multigene metabolic engineer-
ing because it removes any dependence on naturally occurring 
sequences and allows the design of ideal functional genetic circuits 
from first principles. Thus far, most work on synthetic biology has 
been accomplished with microorganisms, in spite of still some 
limiting factors, such as the ability of current methods to assemble 
complex DNA molecules encoding multiple genetic components in 
predefined arrangements (Weber et al., 2011). Simple synthetic 
biology approaches have been described in plants, mostly in the 
context of signaling pathways and development, but also in the 
development of phytodetectors (Zurbriggen et al., 2012) and bio-
fortified crops (Naqvi et al., 2009).
The use of synthetic biology in development as well as me-
tabolism is important because it not only controls the metabolic 
capacity of a cell, but also steps one level up in terms of organiza-
tion and use of particular promoters and genes that control devel-
opmental processes to generate novel tissues, in which the cells 
have specialized biosynthetic or storage functions to accumulate 
target products in particular organs. This approach will facilitate 
the achievement of goals that are unattainable by conventional 
genetic engineering, such as the development of novel organisms 
with medical functions, the production of biofuels, and the removal 
of hazardous waste (Purnick and Weiss, 2009).
Applications of MGT for pathway engineering
Metabolic pathways leading to complex organic molecules, such 
as vitamins (Figs 3, 4 and 5), polyunsaturated fatty acids (Fig. 6), 
and secondary metabolites often comprise a large number of genes, 
enzymes, and feedback mechanisms, limiting our ability to modulate 
these pathways by single-gene transformation. The introduction 
of multiple genes is necessary to understand the bottlenecks and 
identify and complement the rate-limiting steps (Zhu et al., 2008).
The metabolic engineering of vitamin synthesis is necessary 
because many staple crops lack adequate amounts of these vital 
compounds. For example, vitamin A is required (as retinal) for 
blindness prevention and (as retinoic acid) for development and 
maintenance of a healthy immune system; vitamin E is an important 
antioxidant defense compound that quenches free radicals and 
protects against lipid peroxidation (Zhu et al., 2013); and folate 
plays a central metabolic role, including DNA synthesis. None of 
these compounds are present at high levels in cereal grains, and 
more than one half of the world’s population suffers from deficiency 
diseases because they rely on a cereal-based diet (Fitzpatrick et 
al., 2012). Consequently, multigene metabolic engineering in plants 
has focused on carotenoid biosynthesis (vitamin A), tocochromanol 
synthesis (vitamin E), and folate synthesis (Naqvi et al., 2009, 2011).
Polyunsaturated fatty acids (PUFAs) are lipids that are needed 
HMDHP 
DHN DHM 
DHN-P 
DHN-PPP 
GTP 
PABA 
ADC 
Chorismate 
HMDHP 
HMDHP-PP 
Dihydropteroate 
Dihydrofolate 
Tetrahydrofolate 
PolyGlu-tetrahydrofolate 
Plastid Mitochondrion 
GCHI ADCS 
Fig. 5. The plant folate biosynthesis pathway (Naqvi et 
al., 2009). Folates are tripartite molecules consisting of 
pteridine, p-aminobenzoate (PABA), and glutamate moi-
eties, with pteridines synthesized in the cytosol and PABA 
in the plastids. These moieties are transported to the mitochondria, where they condense to form dihydropteroate and are conjugated to glutamate. 
DHN, dihydroneopterin; -P/-PP/-PPP, mono/di/triphosphate; DHM, dihydromonapterin; HMDHP, hydroxymethyldihydropterin.
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not only as energy molecules, but for more specific activities, such 
as maintenance of the nervous system, the immune system, and 
prevention of atherosclerosis (Benatti et al., 2004). PUFAs with 
dual roles as energy providers and essential nutrients include the 
omega-3 group, e.g. a-linolenic acid (ALA), eicosapentaenoic 
acid (EPA), and docosahexaenoic acid (DHA), and the omega-6 
group, e.g. linoleic acid (LA) and arachidonic acid (AA) (Fig. 6). 
Humans cannot synthetize PUFAs because they lack methyl-end 
desaturases, and such modules must be accessed through the 
diet, particularly in fish and other seafood (Benatti et al., 2004). 
Because there is little access to seafood across large parts of 
the world, metabolic engineering has been used to increase the 
abundance of essential PUFAs in transgenic plants.
Finally, secondary metabolites are complex molecules that are 
not required for housekeeping functions, but, nevertheless, provide 
advantages to plants, e.g. by attracting pollinators and repelling 
pests and pathogens. The three major types of secondary metabolite 
are the alkaloids, terpenoids/isoprenoids, and phenolics. Because 
plants have evolved to produce such molecules to control the be-
havior of animals and microbes, many secondary metabolites have 
pharmacological properties in humans or can be used as flavors, 
fragrances, and crop protection products (Miralpeix et al., 2013).
Vitamins
The first use of multigene engineering to modulate the vitamin 
content of plants was the development of Golden Rice (Ye et al., 
2000). This is a transgenic rice line engineered to produce high 
levels of b-carotene through the expression of Pantoea ananatis 
phytoene desaturase (PaCrtI), daffodil (Narcissus spp.) phytoene 
synthase (psy1), and daffodil lycopene b-cyclase (lycb) (Fig. 3). 
The original Golden Rice line produced 1.6 mg/g dry weight (DW) 
of b-carotene, but the replacement of daffodil psy1 with the more 
active maize enzyme in Golden Rice 2 boosted the b-carotene 
content to 31 mg/g DW (Paine et al., 2005).
General strategies to increase carotenoid levels in plants include 
increasing the availability of carotenoid precursors, expressing en-
zymes in the common (linear) part of the pathway, and shifting the 
flux from the a- to the b-branch (Fig. 3). In canola (Brassica napus), 
Agrobacterium-mediated MGT was used to introduce seven different 
transgenes in order to reconstruct the entire carotenoid pathway, 
including an extension which allowed the production of ketocarot-
enoids (Fujisawa et al., 2009). The input genes were isopentenyl 
pyrophosphate isomerase (idi), geranylgeranyldiphosphate (GGPP) 
synthase (CrtE), bacterial phytoene synthase (CrtB), CrtI, lycopene 
b-cyclase (CrtY), and the genes for two additional enzymes (CrtZ 
and CrtW) that catalyze downstream steps converting b-carotene 
into ketocarotenoids. This strategy achieved a 30-fold increase in 
total carotenoid content (657 mg/g fresh weight [FW]) and a 1070-
fold increase in b-carotene (214 mg/g FW). In maize, MGT with 
maize psy1, PaCrtI, lycb of Gentiana lutea (great yellow gentian) 
(Gllycb), and Paracoccus sp. CrtW produced 35.64 mg/g DW of b-
carotene (Zhu et al., 2008). Carotenoid multigene engineering has 
also been applied in tomato, potato, and wheat (Triticum aestivum) 
(Dharmapuri et al., 2002; Diretto et al., 2007; Cong et al., 2009).
The folate biosynthesis pathway (Fig. 4) involves the integra-
tion of two independent branches (pterin and p-aminobenzoate). 
The total folate content can be increased by modulating individual 
enzymes in either branch, but the best results are achieved by 
the simultaneous modulation of both branches by multigene en-
gineering. In the most successful report, a 100-fold increase of 
total folate (38.3 nmol/g FW) was achieved in rice by expression 
of the Arabidopsis thaliana GTP cyclohydrolase 1 (GCH1) and 
aminodeoxychorismate synthase (ADCS) that enhances the the 
cytosolic (pterin) branch and the plastidic p-aminobenzoate branch 
of the pathway, respectively (Storozhenko et al., 2007).
The synthesis of tocochromanols (vitamin E) involves a complex 
pathway (Fig. 5). Vitamin E levels can be elevated by increasing 
the total tocopherol content or enhancing the production of spe-
cific tocochromanols with the most potent vitamin E activity (a-
tocopherol). The constitutive expression of two Arabidopsis cDNA 
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Linoleic acid (LA) C18:2n-6 
γ-Linoleic acid (GLA) C18:3n-6 
Dihomo- γ Linoleic  
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(ARA) C20:4n-6 
Adrenic acid (ADA)  
C22:4n-6 
ω6-docosapentaenoic  
acid (DPA) C22:5n-6 
Omega-3 
α-linoleic acid (ALA) C18:2n-3 
Stearidonic acid (SDA) C18:4n-3 
Eicosatetraenoic acid C20:4n-3 
Eicosapentaenoic acid  
(EPA) C20:5n-3 
Docosapentaenoic acid  
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Docosahexaenoic acid  
(DHA) C22:6n-3 
Δ6 desaturase 
Elongase 
Δ5 desaturase 
Δ4 desaturase 
Elongase 
ω3/Δ15 desaturase 
 ω3/ Δ17 desaturase Fig. 6. The biosynthetic pathway of poly-
unsaturated fatty acids (PUFAs) in plants. 
The conventional Δ6-desaturase/Δ6-elongase 
and the alternative Δ9-elongase pathways start 
from linolenic (LA; 18:2n-6) and a-linolenic acid 
(ALA; 18:3n-3), respectively. PUFAs synthesis 
takes place in plastids. Since mammals lack the 
desaturases which are responsible to produce LA 
and ALA, both of them are considered essential 
fatty acids and must be obtained from the diet. 
Adapted from Vrinten et al., (2007).
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clones encoding p-hydroxyphenylpyruvate dioxygenase (HPPD) 
and 2-methyl-6-phytylplastoquinol methyltransferase (MPBQ MT) 
increased the tocopherol content 3-fold in transgenic maize (Naqvi 
et al., 2011). In soybean, the expression of homogentisate phytyl-
transferase (HPT1), HPPD, TyrA (responsible for the synthesis of 
HPP from prephenate), and geranylgeranyldiphosphate reductase 
(GGDR) increased the tocochromanol content by 15-fold (4806 
mg/g DW) (Karunanandaa et al., 2005).
The current state-of-the-art in vitamin engineering is the si-
multaneous modulation of multiple vitamin pathways in the same 
plant, as reported by Naqvi et al. (2009) through the expression of 
maize psy1 and PaCrtI, representing the carotenoid biosynthesis 
pathway, rice dehydroascorbate reductase (dhar) to increase 
vitamin C (ascorbate) levels, and E. coli FolE to enhance folate 
accumulation (Figs 3, 4 and 5). The transgenic kernels contained 
169-fold the normal amount of b-carotene, 6-fold the normal amount 
of ascorbate, and 2-fold the normal amount of folate.
Long-chain polyunsaturated fatty acids
Several different oil-seed crops have been transformed with 
multiple genes representing the PUFA biosynthesis pathway 
(Sayanova and Napier, 2004). For example, to obtain very long 
chain PUFAs from ALA and LA, it is necessary to introduce at least 
three transgenes encoding the desaturases and elongases required 
for sequential enzymatic reactions (Beaudoin et al., 2000; Hong, 
2002) (Fig. 6). Soybean seeds with higher levels of EPA have 
been produced by expressing Mortierella alpina Δ6-desaturase, 
Δ5-desaturase and Δ6-elongase transgenes plus omega-3Δ17-
desaturase from Saprolegnia diclina, and omega-3Δ15-desaturase 
from Arabidopsis (Kinney et al., 2011) (Fig. 6). This strategy was 
chosen to maximize the accumulation of omega-3 very long 
chain PUFAs by converting omega-6 PUFAs into their omega-3 
counterparts.
Secondary metabolites
Although metabolic engineering can be used to enhance the 
production of secondary metabolites, it is challenging because 
of the complexity of the pathways and the shuffling of precursors 
and intermediates between compartments (Miralpeix et al., 2013). 
The availability of precursors can be augmented by modulating 
the accessibility of basic nitrogen, carbon, and sulfur compounds, 
including the synthesis of amino acids, such as phenylalanine, 
tryptophan and tyrosine, and enhance both primary and secondary 
metabolism simultaneously (Pichersky and Gang, 2000).
Artemisinin is used as a drug against malaria caused by Plas-
modium falciparum and has been produced in transgenic tobacco 
by multigene engineering (Farhi et al., 2011). A mega-vector was 
constructed, containing the Artemisia annua (sweet wormwood) 
genes for cytochrome P450 reductase (CPR), amorpha-4,11-
diene synthase (ADS), amorpha-4,11-diene monooxygenase 
(CYP71AV1), and artemisinic aldehyde Δ-11(13) reductase 
(DBR2), and the yeast 3-hydroxy-3-methylglutaryl coenzyme A 
reductase (HMGR), each under the control of a different pro-
moter. In a separate vector, the ADS sequence was fused to a 
COX4 signal peptide for import into the mitochondria, to boost 
the production of terpenoids. The vectors were introduced into 
tobacco plants by Agrobacterium-mediated transformation and 
the resulting transgenic plants produced amorpha-4,11-diene at 
levels of 26–72 ng/g FW (normal ADS) and 137–827 ng/g fresh 
weight (mitochondrial ADS).
MGT has also been used to boost the production of the natural 
polyester PHB in sugarcane (Saccharum spp.), but required the 
introduction of the enzymes b-ketothiolase (PHAA), acetoacetyl-
reductase (PHAB), and PHB synthase (PHAC) from Ralstonia 
eutropha, and was achieved by particle bombardment with separate 
vectors (Petrasovits et al., 2007). The resulting plants accumulated 
PHB to 1.88% DW in their leaves.
Opium poppy (Papaver somniferum) is one of the most impor-
tant medicinal plants because it is the source of the cancer drug 
noscapine, the muscle relaxant papaverine, and analgesic and 
narcotic drugs, such as morphine and codeine. Morphine-type 
alkaloids have been produced in plant cell cultures since the 
1970s (Rischer et al., 2013). MGT has been used in this case to 
inhibit several genes in a pathway by virus-induced gene silenc-
ing to gain insight into the final six steps of morphine biosynthesis 
(Wijekoon and Facchini, 2012). The inhibition of SalSyn, SalR, 
T6ODM and CODM protein levels correlated with lower morphine 
yields and a substantial increase in the accumulation of reticuline, 
salutaridine, thebaine, and codeine, respectively. In contrast, the 
inhibition of SalAT and COR resulted in higher levels of salutaridine 
and reticuline.
Looking to the future
MGT is becoming essential as a strategy for metabolic engineer-
ing because it is clear that single-point interventions are inadequate 
to achieve ambitious metabolic goals even when dealing with a 
single pathway, and are unsuitable for the simultaneous engineering 
of different pathways, as illustrated by multivitamin corn.
Although it is now straightforward to introduce and express 
5-10 transgenes in the same transgenic line, this is not the ceiling 
of the technique but rather the current status quo. Theoretically, 
there is no maximum number of transgenes that can be introduced 
at once, as demonstrated in microbes in which large, low-copy 
number vectors, such as BACs, P1-derived artificial chromosomes 
in bacteria, and yeast artificial chromosomes, are suitable for the 
introduction of hundreds of genes. This trend is emerging in plants, 
with large-capacity T-DNA-based vectors, but unlinked genes and 
direct DNA transfer allow the use of smaller vectors and achieve 
the same goals, because integration occurs at a single locus, 
therefore providing a suitable platform for strategies based on 
synthetic biology. In order to improve the potential of multigene 
transfer, a combination of linked and unlinked strategies could be 
developed to engineer more complex novel high-flux pathways and 
even combine these with the strategies shown in Fig. 1.
Multigene transfer must still overcome certain practical barriers 
that occur after gene integration, e.g. silencing, transgene rear-
rangement, and interactions between transgenes. As discussed 
above, repeated use of the same promoter does not necessarily 
encourage silencing, but may be a factor when another trigger 
is present; therefore, strategies have been developed based on 
promoter diversity or use of artificial or chimeric promoters to re-
duce the risk of unproductive interactions (Peremarti et al., 2010). 
Novel strategies to assess the risk of transgene rearrangement and 
interactions with surrounding loci include site-specific recombina-
tion, targeted integration, and the use of engineered restriction 
enzymes, especially those based on zinc fingers and transcription 
activator-like effectors (Li et al., 2012).
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Metabolic pathways display a high degree of connectivity in 
larger networks, especially when metabolites are involved in two 
or more pathways; hence, the introduction of a large number of 
input genes has the potential to generate unintended and unpre-
dicted effects. However, an interesting study showed that transfer 
of the entire pathway for dhurrin biosynthesis (a tyrosine-derived 
cyanogenic glucoside) into Arabidopsis had no significant im-
pact on the wider transcriptome and metabolome, whereas the 
transfer of an incomplete pathway induced significant changes in 
morphology, transcriptome, and metabolome, probably through 
metabolic crosstalk or detoxification reactions (Kristensen et al., 
2005). Monitoring changes at the gene, transcript, protein, and 
metabolite levels is a challenge. In the future, it will be necessary 
to integrate these data in the context of systems biology, in which 
modeling is becoming a standard analytical tool for understanding 
whole biological systems and predicting gene behavior (Purnick 
and Weiss, 2009). Systems biology is also a necessary component 
of synthetic biology, because it is critical to foresee the behavior 
of synthetic genetic circuits in the context of the wider organism. 
Advances in systems biology and synthetic biology offer enormous 
potential in terms of development of novel materials and energy 
sources, improvement of agronomic traits, human health applica-
tions, and a better understanding of natural gene regulation (Naqvi 
et al., 2009; Zurbriggen et al., 2012). For example, the expression 
of three genes required for the conversion of acetyl-CoA to PHB 
in plastids allows the production of bioplastics in plants (Bohmert-
Tatarev et al., 2011), and the introduction of five genes of the E. 
coli glycolate catabolic pathway into Arabidopsis thaliana plastids 
reduces the loss of fixed carbon and nitrogen during photorespira-
tion, increasing plant biomass (Kebeish et al., 2007).
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